Piramal Pharma announced the addition of Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to the board of directors. These new appointments, which come ahead of the planned de-merger of PPL from Piramal Enterprises (PEL), will assist in maintaining high governance for the new listed corporate entity.
The appointments will add to the well-diversified experience that currently exists on the PPL board. Led by Chairperson Nandini Piramal and Piramal Global Pharma CEO Peter DeYoung, the Piramal Pharma board also includes leaders such as S Ramadorai, Neeraj Bhardwaj, Jairaj Purandare and Vivek Valsaraj.
Stevenson brings in-depth knowledge in contract manufacturing, business operations, supply chain management and operating in a complex regulatory environment. Gorthi is an authority in corporate law, M&A and private equity. His experience spans manufacturing, pharmaceuticals, insurance, banking and financial services, technology, telecom and media. Leitch is a subject matter expert in pharmaceuticals and the US generics industry, with domain experience in creative product strategies and formulations.
